Kathleen K. Christians, MD

Publications

• Median arcuate ligament release at the time of pancreaticoduodenectomy or total pancreatectomy.

  (Ward EP, Vincent-Sheldon S, Tolat P, Kulkarni N, Aldakkak M, Budithi R, Clarke CN, Tsai S, Evans DB, Christians KK.) Surgery. 2024 May;175(5):1386-1393 PMID: 38413302 SCOPUS ID: 2-s2.0-85186348752 02/28/2024

• Characterization of an oligometastatic state in patients with metastatic pancreatic adenocarcinoma undergoing systemic chemotherapy.

  (de Ortiz de Choudens S, Visotcky A, Banerjee A, Aldakkak M, Tsai S, Evans DB, Christians KK, Clarke CN, George B, Shreenivas A, Kamgar M, Chakrabarti S, Dua KS, Khan AH, Madhavan S, Erickson BA, Hall WA.) Cancer Med. 2023 Dec 22;13(1) PMID: 38140796 PMCID: PMC10807686 SCOPUS ID: 2-s2.0-85180644976 12/23/2023

• Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic Cancer.

  (Thalji SZ, Fernando D, Dua KS, Madhavan S, Chisholm P, Smith ZL, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Evans DB, Tsai S.) Ann Surg. 2023 Dec 01;278(6):e1224-e1231 PMID: 37078282 SCOPUS ID: 2-s2.0-85176508848 04/20/2023

• Patterns of Unnecessary Insurer Prior Authorization Denials in a Complex Surgical Oncology Practice.

  (Merrill JR, Flitcroft MA, Miller T, Beichner B, Clarke CN, Maduekwe UN, Wang TS, Dream S, Christians KK, Gamblin TC, Evans DB, Kothari AN.) J Surg Res. 2023 Aug;288:269-274 PMID: 37037166 SCOPUS ID: 2-s2.0-85151667989 04/11/2023

• Automated machine learning (AutoML) can predict 90-day mortality after gastrectomy for cancer.

  (SenthilKumar G, Madhusudhana S, Flitcroft M, Sheriff S, Thalji S, Merrill J, Clarke CN, Maduekwe UN, Tsai S, Christians KK, Gamblin TC, Kothari AN.) Sci Rep. 2023 Jul 08;13(1):11051 PMID: 37422500 PMCID: PMC10329647 SCOPUS ID: 2-s2.0-85164146540 07/09/2023

• Neoadjuvant chemotherapy for pancreatic cancer: Quality over quantity.

  (Thalji SZ, Aldakkak M, Christians KK, Clarke CN, George B, Kamgar M, Erickson BA, Hall WA, Chisholm P, Kulkarni N, Doucette S, Evans DB, Tsai S.) J Surg Oncol. 2023 Jul;128(1):41-50 PMID: 36960919 SCOPUS ID: 2-s2.0-85152449940 03/25/2023

• ASO Visual Abstract: CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/ nab-Paclitaxel for Patients with Operable Pancreatic Cancer.

  (Thalji SZ, Kamgar M, George B, Aldakkak M, Christians KK, Clarke CN, Erickson BA, Hall WA, Tolat PP, Smith ZL, Evans DB, Tsai S.) Ann Surg Oncol. 2023 May;30(5):3022 PMID: 36877324 SCOPUS ID: 2-s2.0-85152164746 03/07/2023

• CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer.

  (Thalji SZ, Kamgar M, George B, Aldakkak M, Christians KK, Clarke CN, Erickson BA, Hall WA, Tolat PP, Smith ZL, Evans DB, Tsai S.) Ann Surg Oncol. 2023 May;30(5):3013-3021 PMID: 36788189 SCOPUS ID: 2-s2.0-85147934173 02/15/2023

• Automated machine learning (AutoML) can predict 90-day mortality after gastrectomy for cancer

  (SenthilKumar G, Madhusudhana S, Flitcroft M, Sheriff S, Thalji S, Merrill J, Clarke CN, Maduekwe UN, Tsai S, Christians KK, Gamblin TC, Kothari AN.) Scientific Reports. December 2023;13(1) SCOPUS ID: 2-s2.0-85164146540 12/01/2023

• Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial.

  (Hohneck A, Meissner R, Reyser C, Heinemann L, Christians K, Merx K, Weingärtner S, Mavratzas A, Schulte N, Burkholder I, Hofmann WK, Hofheinz RD.) Oncol Res Treat. 2023;46(1-2):1-10 PMID: 36657417 PMCID: PMC10015753 01/20/2023

• Palliative Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis: Is It Safe and Effective?

  (Strong EA, Livingston A, Gracz M, Peltier W, Tsai S, Christians K, Gamblin TC, Kersting K, Clarke CN.) J Surg Res. 2022 Oct;278:31-38 PMID: 35588572 SCOPUS ID: 2-s2.0-85130316020 05/20/2022

• Updates and new directions in the use of radiation therapy for the treatment of pancreatic adenocarcinoma: dose, sensitization, and novel technology.

  (Hall WA, Kamgar M, Erickson BA, Ponce SB, Tsai S, Nevalainen MT, Christians KK, George B, Dua KS, Khan AH, Evans DB, Azmi AS.) Cancer Metastasis Rev. 2021 Sep;40(3):879-889 PMID: 34611794 PMCID: PMC8767496 SCOPUS ID: 2-s2.0-85116412346 10/07/2021